Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients
Table 1
Comparison between age, liver functions, and blood counts in the studied groups.
Group
Range
Mean
S.E
value
value
Age (year)
Control
33–77
51.50
2.48
2.313
0.083
HCV
33–71
55.05
2.02
LC
32–78
55.60
2.43
HCC
35–76
60.15
2.39
T BIL (mg %)
Control
0.4–0.9
0.70a
0.03
5.061
0.003*
HCV
1–5.4
2.65b
0.32
LC
1.1–34
5.74c
1.80
HCC
1.5–6
2.72b
0.30
D BIL (mg %)
Control
0.1–0.29
0.19a
0.09
6.238
0.001*
HCV
0.2–2.5
1.20b
0.16
LC
0.4–14.2
2.69c
0.82
HCC
0–1.9
0.72b
0.09
AST (u/L)
Control
13–34
22.05a
1.27
14.673
0.000*
HCV
30–108
69.80b
4.36
LC
31–402
96.45b
20.21
HCC
80–300
133.35c
13.00
ALT (u/L)
Control
11–31
17.35a
1.18
11.516
0.000*
HCV
32–176
92.90c
8.33
LC
12–255
75.25b
16.55
HCC
34–103
64.65b
4.19
Alb (g/dL)
Control
2.8–5.1
4.01b
0.12
25.608
0.000*
HCV
1.9–3.6
2.76a
0.12
LC
1.3–3.9
2.53a
0.16
HCC
1.7–3.4
2.79a
0.12
Proth (sec)
Control
13–16
14.05
0.20
1.983
0.124
HCV
14–19
16.20
0.34
LC
11.7–67
18.95
2.82
HCC
14.2–19.6
15.80
0.43
TLC (103/cmm)
Control
4–10.2
6.97
0.42
1.732
0.168
HCV
3.1–16.2
8.40
0.70
LC
3–36.1
10.37
1.69
HCC
3–36.1
10.37
1.69
HB (g/dL)
Control
12.1–15.7
13.72c
0.25
12.505
0.000*
HCV
6.1–13
9.90a
0.55
LC
4.1–16
10.09a
0.70
HCC
9–15
11.80b
0.39
Hct (%)
Control
40–50
42b
0.01
188.062
0.000*
HCV
20–40
31b
0.01
LC
13–44.4
28.97a
1.70
HCC
13.3–44.4
28.97a
1.70
Plat (103/cmm)
Control
150–450
262.10b
15.83
16.161
0.000*
HCV
73–431
233.95b
20.60
LC
48–331
161.60a
17.03
HCC
60–160
123.85a
6.43
S.E: standard error. There is a significant difference between groups at . The same letter means that there is no significant difference between each two groups at . The different letters means that there is a significant difference between each two groups at .
